Your browser doesn't support javascript.
loading
Presumptive isolated neurosarcoidosis involving eloquent structures: An argument for empirical TNF-α inhibition.
Law, Lai Yin; Barnett, Michael H; Barnett, Yael; Masters, Lynette; Beadnall, Heidi N; Hardy, Todd A; Reddel, Stephen W.
Afiliação
  • Law LY; Neuroimmunology Clinic, Concord Hospital, University of Sydney, NSW, Australia; St Vincent's Hospital Melbourne, VIC, Australia.
  • Barnett MH; Brain and Mind Centre, University of Sydney NSW, Australia.
  • Barnett Y; Brain and Mind Centre, University of Sydney NSW, Australia.
  • Masters L; Brain and Mind Centre, University of Sydney NSW, Australia.
  • Beadnall HN; Brain and Mind Centre, University of Sydney NSW, Australia.
  • Hardy TA; Neuroimmunology Clinic, Concord Hospital, University of Sydney, NSW, Australia.
  • Reddel SW; Neuroimmunology Clinic, Concord Hospital, University of Sydney, NSW, Australia. Electronic address: swreddel@sydneyneurology.com.au.
J Neuroimmunol ; 372: 577956, 2022 11 15.
Article em En | MEDLINE | ID: mdl-36054936
ABSTRACT
There are clinical and radiological phenotypes characteristic of neurosarcoidosis. Histopathologic confirmation is preferred, however, biopsy is associated with a significant risk of morbidity when only eloquent neural structures are involved and where there is no systemic disease. We present a series of patients with isolated neurosarcoidosis and suggest circumstances where an empirical, closely monitored, trial of tumour-necrosis-factor-alpha inhibitor therapy can improve outcome and diagnostic confidence.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoidose / Doenças do Sistema Nervoso Central Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoidose / Doenças do Sistema Nervoso Central Idioma: En Ano de publicação: 2022 Tipo de documento: Article